You are here

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, December 30, 2022 - 12:00
Conditions:   Myocardial Infarction;   Myocardial Ischemia;   Myocardial Stunning
Intervention:   Biological: mitochondria and MSC-derived exosomes
Sponsor:   Tehran University of Medical Sciences
Posted: Wednesday, November 30, 2022 - 12:00
Conditions:   Ischemic Heart Disease;   Ischemic Cardiomyopathy;   Heart Failure, Systolic;   Heart Failure NYHA Class III;   Heart Failure NYHA Class II;   Heart Failure NYHA Class IV;   Coronary Artery Disease
Interventions:   Procedure: Epicardial AAMs-patch transplantation;   Diagnostic Test: RNA-stabilized whole blood sampling;   Diagnostic Test: Plasma sampling;   Diagnostic Test: Transthoracic echocardiography;   Diagnostic Test: Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI);   Other: Symptom-scaling;   Other: 6-minute walking test (6MWT);   Diagnostic Test: Blood sampling (NT-proBNP);   Diagnostic Test: Transesophageal echocardiography
Sponsors:   Hospital District of Helsinki and Uusimaa;   University of Helsinki
Not yet recruiting
Posted: Tuesday, November 22, 2022 - 12:00
Conditions:   Myocardial Reperfusion Injury;   Treatment Outcome;   Prognosis;   ST Elevation Myocardial Infarction
Intervention:   Device: Extracorporeal cardiac shock wave therapy(ECSW)
Sponsor:   The First Affiliated Hospital of Kunming Medical College
Not yet recruiting
Posted: Wednesday, October 26, 2022 - 12:00
Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Intervention:   Biological: Autologuos transplantation of bronchial basal cells
Sponsors:   Guangzhou Institute of Respiratory Disease;   Regend Therapeutics
Posted: Friday, June 10, 2022 - 12:00
Conditions:   Heart Disease, Ischemic;   Hyperlipidemias;   Hypertension
Intervention:   Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor:   University of Rochester
Not yet recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Conditions:   Congestive Heart Failure;   Angina
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Wednesday, October 6, 2021 - 12:00
Condition:   Chronic Ischemic Left Ventricular Dysfunction
Interventions:   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells;   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells;   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells
Sponsor:   Joseph C. Wu
Not yet recruiting
Posted: Tuesday, September 14, 2021 - 12:00
Conditions:   Myocardial Infarction, Acute;   Myocardial Infarction First;   Myocardial Infarction, Anterior Wall;   Cardiac Remodeling, Ventricular;   STEMI;   Regenerative Medicine;   Heart Failure
Interventions:   Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs);   Other: Conventional Treatment
Sponsors:   Shiraz University of Medical Sciences;   National Institute of Medical Research Development (NIMAD), Iran;   Cell Tech Pharmed Company, Iran
Posted: Monday, August 9, 2021 - 12:00
Conditions:   Ischemic Heart Disease;   Lung Injury;   Non-cardiac Surgery
Interventions:   Biological: human umbilical cord-derived mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Posted: Thursday, August 5, 2021 - 12:00
Condition:   Heart Failure, Systolic
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Other: human serum albumin
Sponsor:   Shanghai East Hospital
Not yet recruiting